Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 90

Sort by

Sort Order Select

Journal Articles

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Evangelos Terpos, MD PhD, Despina Fotiou, MD, Konstantinos Anargyrou, MD, Theodoros P. Vassilakopoulos, MD PhD, Dimitrios Christoulas, MD, Polyzois Makras, MD PhD, Maria Dimou, MD PhD, Ioannis Ntanasis-Stathopoulos, MD, Stavroula Masouridou, MD, Maria K. Angelopoulou, MD, Athanasios Papatheodorou, PhD, Konstantinos Tsionos, MD, Panayiotis Panayiotidis, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4124.

https://doi.org/10.1182/blood-2019-123615

Published: 2019

Journal Articles

Maximizing FDG-PET/CT Utility in Staging of Follicular Lymphoma (FL): The Role of Spleen Involvement and Bone Standardized Uptake Values

Frederique St-Pierre, MD, Stephen Broski, MD, Betsy Laplant, MS, Thomas M. Habermann, MD, Thomas E. Witzig, MD

Blood (2019) 134 (Supplement_1): 2811.

https://doi.org/10.1182/blood-2019-131992

Published: 2019

Journal Articles

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

Stephen Booth, MA,MBBChir,MRCP,FRCPath, Hannah Plaschkes, Amy A Kirkwood, Adam Gibb, MBBS, Patrick Horgan, Joanna M Oladipo, Joseph Andrew Browning, DPhil,BMBCh, Usman Khan, John Willan, Julia Wolf, Arief Gunawan, MBBS, BSc, MRCP, Paul A Fields, MD PhD, Kim Linton, MBChB PhD, Claire Higham, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Jaimal Kothari, Catherine Hildyard, Toby A. Eyre

Blood (2019) 134 (Supplement_1): 1615.

https://doi.org/10.1182/blood-2019-127374

Published: 2019

Journal Articles

The Characteristics, Treatment Patterns, and Outcomes of Older Adults with Multiple Myeloma

Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI, Mark A. Schroeder, MD, Armin Ghobadi, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MBBS

Blood (2018) 132 (Supplement 1): 4463.

https://doi.org/10.1182/blood-2018-99-118660

Published: 2018

Journal Articles

Risk and Prognostic Factors of Extra-Nodal Hodgkin Lymphoma: Single Jordanian Center Experience

Tariq Zuheir Kewan, MD, Deeb Jamil Zahran, MD MBBS, Abdel-Hameed WASFI AL-Mistarehi, MD, Hassan Awada, MD, Valentina Giudice, MD, Valeria Visconte, PhD, Mahmoud H Ayesh (Haj Yousef), Associate Professor of Internal MDcine/ Hematology

Blood (2018) 132 (Supplement 1): 5358.

https://doi.org/10.1182/blood-2018-99-111737

Published: 2018

Journal Articles

Long-Term Effects of Oral Eliglustat on Skeletal Manifestations of Gaucher Disease Type 1: Results from Four Completed Clinical Trials

Pramod K. Mistry, MD PhD FRCP, Joel Charrow, MD, Timothy Cox, MD, Elena Lukina, MD PhD, Theodore Marinakis, MD, Meredith C. Foster, ScD, Sebastiaan J.M. Gaemers, MD, Judith Peterschmitt, MD

Blood (2018) 132 (Supplement 1): 2396.

https://doi.org/10.1182/blood-2018-99-117289

Published: 2018

Journal Articles

Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study

Blood (2018) 132 (Supplement 1): 3289.

https://doi.org/10.1182/blood-2018-99-112846

Published: 2018

Journal Articles

Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Jenny Willson, Amanda Bruno, Joanna Opalinska, Jeannene Nelson, Orsolya Lunacsek, Dana Stafkey-Mailey, Joanne Willey

Blood (2018) 132 (Supplement 1): 3290.

https://doi.org/10.1182/blood-2018-99-112954

Published: 2018

Journal Articles

Prognosis after Upfront Radiation Therapy in Plasma Cell Myeloma: Analysis of the National Cancer Data Base

Xavier Orcutt, BA, Peter Barth, MD, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 3230.

https://doi.org/10.1182/blood-2018-99-110108

Published: 2018

Journal Articles

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Walter Bertolami, MD, Paola Anna Erba, Francesco Caracciolo, Edoardo Benedetti, MD, Enrico Orciuolo, Gabriele Buda, PhD MD, Riccardo Morganti, Sara Galimberti, PhD MD, Mario Petrini, PhD MD Prof

Blood (2017) 130 (Supplement 1): 5522.

https://doi.org/10.1182/blood.V130.Suppl_1.5522.5522

Published: 2017

Journal Articles

Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm

William Morello, MD, Mirella Filocamo, Marina Stroppiano, Maja Di Rocco, MD, Nicola Tovaglieri, MD, Giovanna Russo, MD, Francesca Furlan, MD, Roberta Burnelli, MD, Andrea Pession, MD

Blood (2017) 130 (Supplement 1): 1187.

https://doi.org/10.1182/blood.V130.Suppl_1.1187.1187

Published: 2017

Journal Articles

Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma

Vassilis Koutoulidis, Evangelos Terpos, MD PhD, Ioannis Ntanasis-Stathopoulos, Flora Zagouri, Ioanna Klapa, Andriani Boultadaki, Maria Gavriatopoulou, Sophia Fontara, Eftathios Kastritis, Meletios A. Dimopoulos, Lia A. Moulopoulos

Blood (2017) 130 (Supplement 1): 4404.

https://doi.org/10.1182/blood.V130.Suppl_1.4404.4404

Published: 2017

Journal Articles

Novel CT-Based Bone Strength Assessment By Finite Element Analysis for Monitoring Bone Involvement in Myeloma: a Proof of Concept Study

Yael C Cohen, Irit Avivi, MD, Zohar Yosibash, DSc, Nir Trabelsi, PhD, Hagai Sherman, MD, Amir Sternheim

Blood (2017) 130 (Supplement 1): 3143.

https://doi.org/10.1182/blood.V130.Suppl_1.3143.3143

Published: 2017

Journal Articles

Myeloma Lytic Bone Lesions Characterization with WB-LDCT and 18 f-FDG PET/MRI

Albana Lico, MD, Gregorio Barilà, MD, Filippo Crimì, MD, Lucia Checuz, MD, Tamara Berno, MD, Stefania Vio, MD, Antonio Branca, MD, Lucia Ammirati, MD, Matteo Leoncin, MD, Pietro Zucchetta, MD, Carmelo Lacognata, MD, Francesco Piazza, MD, Gianpietro Semenzato, MD, Renato Zambello, MD

Blood (2017) 130 (Supplement 1): 1788.

https://doi.org/10.1182/blood.V130.Suppl_1.1788.1788

Published: 2017

Journal Articles

Risk Factors of Central Nervous System Involvement in Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Mahmoud Husni Hajyousef, MD, Associate Professor, Tariq Zuheir Kewan, MD, Deeb Jamil Zahran, MD, Sohaib Mahmoud Al-Khatib, MD

Blood (2017) 130 (Supplement 1): 5227.

https://doi.org/10.1182/blood.V130.Suppl_1.5227.5227

Published: 2017

Journal Articles

Alkaline Phosphatase Serum Level at Time of Diagnosis Is a Prognostic Marker in Patients with Hodgkin Lymphoma

Tariq Zuheir Kewan, MD, Mahmoud Husni Hajyousef, MD, Associate Professor, Deeb Jamil Zahran, MD, Sohaib Mahmoud Al-Khatib, MD

Blood (2017) 130 (Supplement 1): 5187.

https://doi.org/10.1182/blood.V130.Suppl_1.5187.5187

Published: 2017

Journal Articles

Correlation between Bone Disease and Genotype in Patients with Type 1 Gaucher Disease. Data from the Spanish Gaucher Disease Registry

Marcio Andrade-Campos, PhD, Pilar Irun, PhD, Mercedes Roca-Espiau, PhD, Pilar Giraldo, PhD

Blood (2017) 130 (Supplement 1): 3571.

https://doi.org/10.1182/blood.V130.Suppl_1.3571.3571

Published: 2017

Journal Articles

Long-Term Follow-up of Primary Bone Diffuse Large B-Cell Lymphoma Treated with m NHL-BFM-90

Nelly G. Gabeeva, PhD, Eugene E. Zvonkov, MD PhD, Anna K. Morozova, Daria A. Koroleva, MD, Alla M. Kovrigina, MD PhD Prof., Valery Grigorievich Savchenko, MD PhD academician

Blood (2016) 128 (22): 3025.

https://doi.org/10.1182/blood.V128.22.3025.3025

Published: 2016

Journal Articles

Efficacy of Novel Agents on Soft-Tissue Plasmacytomas in Patients with Relapsed Multiple Myeloma

Raquel Jiménez-Segura, PhD, Carlos Fernández De Larrea, MD PhD, Maite Cibeira, MD PhD, Natalia Tovar, Esther Bladé, Ignacio Isola, MD PhD, Joan Bladé, Laura Rosiñol

Blood (2016) 128 (22): 5709.

https://doi.org/10.1182/blood.V128.22.5709.5709

Published: 2016

Journal Articles

Venous Thromboembolic Events in Diffuse Large B Cell Lymphoma Patients: Risk Factors and Outcomes

Sabarish Ram Ayyappan, MBBS, Vinita Gupta, MD, Akiva Diamond, MD, Brenda Cooper, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Leland Metheny, MD, Hillard M. Lazarus, MD, Stanton L. Gerson, MD, Marcos De Lima, MD, Paolo F. Caimi, MD

Blood (2016) 128 (22): 3611.

https://doi.org/10.1182/blood.V128.22.3611.3611

Published: 2016

NARROW

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Maximizing FDG-PET/CT Utility in Staging of Follicular Lymphoma (FL): The Role of Spleen Involvement and Bone Standardized Uptake Values

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

The Characteristics, Treatment Patterns, and Outcomes of Older Adults with Multiple Myeloma

Risk and Prognostic Factors of Extra-Nodal Hodgkin Lymphoma: Single Jordanian Center Experience

Long-Term Effects of Oral Eliglustat on Skeletal Manifestations of Gaucher Disease Type 1: Results from Four Completed Clinical Trials

Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study

Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Prognosis after Upfront Radiation Therapy in Plasma Cell Myeloma: Analysis of the National Cancer Data Base

PET-CT Does Not Impact on the Outcome of the Patients Affected By Multiple Myeloma after Autologous Transplantation: A Real Life Experience

Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm

Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma

Novel CT-Based Bone Strength Assessment By Finite Element Analysis for Monitoring Bone Involvement in Myeloma: a Proof of Concept Study

Myeloma Lytic Bone Lesions Characterization with WB-LDCT and 18 f-FDG PET/MRI

Risk Factors of Central Nervous System Involvement in Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Alkaline Phosphatase Serum Level at Time of Diagnosis Is a Prognostic Marker in Patients with Hodgkin Lymphoma

Correlation between Bone Disease and Genotype in Patients with Type 1 Gaucher Disease. Data from the Spanish Gaucher Disease Registry

Long-Term Follow-up of Primary Bone Diffuse Large B-Cell Lymphoma Treated with m NHL-BFM-90

Efficacy of Novel Agents on Soft-Tissue Plasmacytomas in Patients with Relapsed Multiple Myeloma

Venous Thromboembolic Events in Diffuse Large B Cell Lymphoma Patients: Risk Factors and Outcomes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only